NuCana is trading 6.25% up at $1.02 on October 23, 2026, with no verified company-specific catalyst identified.
- Available coverage shows the European patent news for NUC-7738 dates to September 30 and is not a fresh catalyst.
- Broader conditions do not clearly explain the gain: reports cite risk-off pressure from higher oil prices and geopolitical tensions, while the biotech sector is also lower.